“Understanding the disparities in diagnostic breast imaging can facilitate the development of interventions that aim to close gaps," says Marissa B. Lawson, MD. 

The company seeks to “organize the world’s medical images,” serving as a data marketplace for biopharma firms, researchers, physicians and AI companies.  

The duo announced the partnership on Monday, stating that the collaboration marks “a shift in how healthcare institutions approach data.” 

New data suggest the model outperforms publicly available segmentation algorithms.  

A U.S. military contractor has agreed to an $11.2 million settlement with the U.S. Department of Justice to resolve allegations it lied about properly securing sensitive patient data tied to the Tricare program.

In an SEC filing, the insurer argues that requests by investors for more reporting on claims denials may already be satisfied through its regulatory compliance processes. 

Add this to the list of high-risk healthcare activities to which generative AI can contribute: prescribing antibiotics. 

Researchers used advanced AI to see if any FDA-approved medications could potentially reverse one of the mutations behind dilated cardiomyopathy. Risedronate, a popular osteoporosis medication, is the one candidate that got the job done.

Johnson & Johnson MedTech has resumed the U.S. rollout of its Varipulse PFA system, sharing new warnings to help physicians. 

Military veterans face an increased risk of cardiovascular disease, making it especially important to ensure they receive high-quality care.